Thursday, May 15, 2025
PAVmed Inc. (PAVM) Q1 2025 Ear
PAVmed Inc. (NASDAQ:PAVM) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsMatt Riley - Senior Director of Investor...
Friday, April 11, 2025
Lucid Diagnostics Announces Cl
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the c
Wednesday, April 9, 2025
Lucid Diagnostics Announces Pr
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the p
Wednesday, April 9, 2025
Lucid Diagnostics Announces Pr
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its i
Thursday, April 3, 2025
Lucid Diagnostics to Participa
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that L
Thursday, March 27, 2025
Lucid Diagnostics Launches "Em
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced a cam
Wednesday, March 26, 2025
PAVmed Inc (PAVM) Q4 2024 Earn
PAVmed Inc (PAVM) reports significant growth in test volumes and revenue, while securing strategic partnerships and funding to bolster future operations.
Tuesday, March 25, 2025
PAVmed Provides Business Updat
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda
Tuesday, March 25, 2025
PAVmed Inc. (PAVM) Q4 2024 Ear
PAVmed Inc. (NASDAQ:PAVM) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ETCompany ParticipantsMatt Riley - Senior Director of IRLishan Aklog -...
Tuesday, March 25, 2025
PAVmed Inc. 2024 Q4 - Results
The following slide deck was published by PAVmed Inc.
Monday, March 24, 2025
Lucid Diagnostics Provides Bus
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), toda
Thursday, March 20, 2025
Lucid Diagnostics Announces Up
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Tuesday, March 18, 2025
Lucid Diagnostics' ENVET-BE Cl
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that i
Thursday, March 13, 2025
Lucid Diagnostics Secures Firs
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that H
Tuesday, March 11, 2025
PAVmed to Hold a Business Upda
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda
Monday, March 10, 2025
Lucid Diagnostics to Hold a Bu
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it
Wednesday, March 5, 2025
Lucid Diagnostics Announces Cl
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the c
Tuesday, March 4, 2025
Lucid Diagnostics Announces $1
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Thursday, February 27, 2025
Renowned Investigators Awarded
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Tuesday, February 25, 2025
Lucid Diagnostics Regains Comp
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Monday, February 24, 2025
PAVmed and Subsidiary Veris He
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majo
Thursday, February 20, 2025
Lucid Diagnostics Executes Fir
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that i
Tuesday, February 18, 2025
PAVmed Regains Compliance with
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda
Thursday, February 6, 2025
Lucid Diagnostics to Participa
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its pa
Monday, January 13, 2025
Lucid Diagnostics Announces Re
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced it per
Monday, December 23, 2024
Lucid Diagnostics Granted 180-
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that i
Thursday, December 19, 2024
Lucid Diagnostics Partners wit
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that i
Wednesday, December 11, 2024
Prospective Clinical Utility S
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that t
Tuesday, December 3, 2024
Lucid Diagnostics Completes Co
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the su
Wednesday, November 20, 2024
Lucid Diagnostics Submits Clin
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it
Monday, November 18, 2024
Lucid Diagnostics to Present a
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Sunday, November 17, 2024
PAVmed Third Quarter 2024 Earn
PAVmed ( NASDAQ:PAVM ) Third Quarter 2024 Results Key Financial Results Net income: US$64.3m (up from US$17.7m loss in...
Friday, November 15, 2024
PAVmed Inc (PAVM) Q3 2024 Earn
PAVmed Inc (PAVM) reports a transformative quarter with a 20% revenue increase and key financial maneuvers to strengthen its corporate structure.
Thursday, November 14, 2024
PAVmed Inc. (PAVM) Q3 2024 Ear
PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ETCompany ParticipantsMatt Riley - Director of IRLishan Aklog -...
Thursday, November 14, 2024
PAVmed Inc. 2024 Q3 - Results
The following slide deck was published by PAVmed Inc.
Thursday, November 14, 2024
PAVmed Provides Business Updat
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda
Thursday, November 7, 2024
Lucid Diagnostics' ESOGUARD BE
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that th
Tuesday, November 5, 2024
Lucid Diagnostics Expands Dire
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Thursday, October 31, 2024
PAVmed to Hold a Business Upda
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, toda
Wednesday, October 30, 2024
Lucid Diagnostics to Hold a Bu
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it
Tuesday, October 15, 2024
Lucid Diagnostics Receives Not
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Thursday, October 10, 2024
PAVmed Subsidiary, Veris Healt
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majo
Wednesday, October 9, 2024
Lucid Diagnostics to Participa
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Tuesday, October 8, 2024
Lucid Diagnostics to Join Glob
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Tuesday, October 1, 2024
Lucid Diagnostics Holds Inaugu
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that
Tuesday, September 24, 2024
American Foregut Society's 202
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), announced that the Amer